Cargando…
Why do hospital prescribers continue antibiotics when it is safe to stop? Results of a choice experiment survey
BACKGROUND: Deciding whether to discontinue antibiotics at early review is a cornerstone of hospital antimicrobial stewardship practice worldwide. In England, this approach is described in government guidance (‘Start Smart then Focus’). However, < 10% of hospital antibiotic prescriptions are disc...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7391515/ https://www.ncbi.nlm.nih.gov/pubmed/32727604 http://dx.doi.org/10.1186/s12916-020-01660-4 |
_version_ | 1783564651209949184 |
---|---|
author | Roope, Laurence S. J. Buchanan, James Morrell, Liz Pouwels, Koen B. Sivyer, Katy Mowbray, Fiona Abel, Lucy Cross, Elizabeth L. A. Yardley, Lucy Peto, Tim Walker, A. Sarah Llewelyn, Martin J. Wordsworth, Sarah |
author_facet | Roope, Laurence S. J. Buchanan, James Morrell, Liz Pouwels, Koen B. Sivyer, Katy Mowbray, Fiona Abel, Lucy Cross, Elizabeth L. A. Yardley, Lucy Peto, Tim Walker, A. Sarah Llewelyn, Martin J. Wordsworth, Sarah |
author_sort | Roope, Laurence S. J. |
collection | PubMed |
description | BACKGROUND: Deciding whether to discontinue antibiotics at early review is a cornerstone of hospital antimicrobial stewardship practice worldwide. In England, this approach is described in government guidance (‘Start Smart then Focus’). However, < 10% of hospital antibiotic prescriptions are discontinued at review, despite evidence that 20–30% could be discontinued safely. We aimed to quantify the relative importance of factors influencing prescriber decision-making at review. METHODS: We conducted an online choice experiment, a survey method to elicit preferences. Acute/general hospital prescribers in England were asked if they would continue or discontinue antibiotic treatment in 15 hypothetical scenarios. Scenarios were described according to six attributes, including patients’ presenting symptoms and whether discontinuation would conflict with local prescribing guidelines. Respondents’ choices were analysed using conditional logistic regression. RESULTS: One hundred respondents completed the survey. Respondents were more likely to continue antibiotics when discontinuation would ‘strongly conflict’ with local guidelines (average marginal effect (AME) on the probability of continuing + 0.194 (p < 0.001)), when presenting symptoms more clearly indicated antibiotics (AME of urinary tract infection symptoms + 0.173 (p < 0.001) versus unclear symptoms) and when patients had severe frailty/comorbidities (AME = + 0.101 (p < 0.001)). Respondents were less likely to continue antibiotics when under no external pressure to continue (AME = − 0.101 (p < 0.001)). Decisions were also influenced by the risks to patient health of continuing/discontinuing antibiotic treatment. CONCLUSIONS: Guidelines that conflict with antibiotic discontinuation (e.g. pre-specify fixed durations) may discourage safe discontinuation at review. In contrast, guidelines conditional on patient factors/treatment response could help hospital prescribers discontinue antibiotics if diagnostic information suggesting they are no longer needed is available. |
format | Online Article Text |
id | pubmed-7391515 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-73915152020-07-31 Why do hospital prescribers continue antibiotics when it is safe to stop? Results of a choice experiment survey Roope, Laurence S. J. Buchanan, James Morrell, Liz Pouwels, Koen B. Sivyer, Katy Mowbray, Fiona Abel, Lucy Cross, Elizabeth L. A. Yardley, Lucy Peto, Tim Walker, A. Sarah Llewelyn, Martin J. Wordsworth, Sarah BMC Med Research Article BACKGROUND: Deciding whether to discontinue antibiotics at early review is a cornerstone of hospital antimicrobial stewardship practice worldwide. In England, this approach is described in government guidance (‘Start Smart then Focus’). However, < 10% of hospital antibiotic prescriptions are discontinued at review, despite evidence that 20–30% could be discontinued safely. We aimed to quantify the relative importance of factors influencing prescriber decision-making at review. METHODS: We conducted an online choice experiment, a survey method to elicit preferences. Acute/general hospital prescribers in England were asked if they would continue or discontinue antibiotic treatment in 15 hypothetical scenarios. Scenarios were described according to six attributes, including patients’ presenting symptoms and whether discontinuation would conflict with local prescribing guidelines. Respondents’ choices were analysed using conditional logistic regression. RESULTS: One hundred respondents completed the survey. Respondents were more likely to continue antibiotics when discontinuation would ‘strongly conflict’ with local guidelines (average marginal effect (AME) on the probability of continuing + 0.194 (p < 0.001)), when presenting symptoms more clearly indicated antibiotics (AME of urinary tract infection symptoms + 0.173 (p < 0.001) versus unclear symptoms) and when patients had severe frailty/comorbidities (AME = + 0.101 (p < 0.001)). Respondents were less likely to continue antibiotics when under no external pressure to continue (AME = − 0.101 (p < 0.001)). Decisions were also influenced by the risks to patient health of continuing/discontinuing antibiotic treatment. CONCLUSIONS: Guidelines that conflict with antibiotic discontinuation (e.g. pre-specify fixed durations) may discourage safe discontinuation at review. In contrast, guidelines conditional on patient factors/treatment response could help hospital prescribers discontinue antibiotics if diagnostic information suggesting they are no longer needed is available. BioMed Central 2020-07-30 /pmc/articles/PMC7391515/ /pubmed/32727604 http://dx.doi.org/10.1186/s12916-020-01660-4 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Article Roope, Laurence S. J. Buchanan, James Morrell, Liz Pouwels, Koen B. Sivyer, Katy Mowbray, Fiona Abel, Lucy Cross, Elizabeth L. A. Yardley, Lucy Peto, Tim Walker, A. Sarah Llewelyn, Martin J. Wordsworth, Sarah Why do hospital prescribers continue antibiotics when it is safe to stop? Results of a choice experiment survey |
title | Why do hospital prescribers continue antibiotics when it is safe to stop? Results of a choice experiment survey |
title_full | Why do hospital prescribers continue antibiotics when it is safe to stop? Results of a choice experiment survey |
title_fullStr | Why do hospital prescribers continue antibiotics when it is safe to stop? Results of a choice experiment survey |
title_full_unstemmed | Why do hospital prescribers continue antibiotics when it is safe to stop? Results of a choice experiment survey |
title_short | Why do hospital prescribers continue antibiotics when it is safe to stop? Results of a choice experiment survey |
title_sort | why do hospital prescribers continue antibiotics when it is safe to stop? results of a choice experiment survey |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7391515/ https://www.ncbi.nlm.nih.gov/pubmed/32727604 http://dx.doi.org/10.1186/s12916-020-01660-4 |
work_keys_str_mv | AT roopelaurencesj whydohospitalprescriberscontinueantibioticswhenitissafetostopresultsofachoiceexperimentsurvey AT buchananjames whydohospitalprescriberscontinueantibioticswhenitissafetostopresultsofachoiceexperimentsurvey AT morrellliz whydohospitalprescriberscontinueantibioticswhenitissafetostopresultsofachoiceexperimentsurvey AT pouwelskoenb whydohospitalprescriberscontinueantibioticswhenitissafetostopresultsofachoiceexperimentsurvey AT sivyerkaty whydohospitalprescriberscontinueantibioticswhenitissafetostopresultsofachoiceexperimentsurvey AT mowbrayfiona whydohospitalprescriberscontinueantibioticswhenitissafetostopresultsofachoiceexperimentsurvey AT abellucy whydohospitalprescriberscontinueantibioticswhenitissafetostopresultsofachoiceexperimentsurvey AT crosselizabethla whydohospitalprescriberscontinueantibioticswhenitissafetostopresultsofachoiceexperimentsurvey AT yardleylucy whydohospitalprescriberscontinueantibioticswhenitissafetostopresultsofachoiceexperimentsurvey AT petotim whydohospitalprescriberscontinueantibioticswhenitissafetostopresultsofachoiceexperimentsurvey AT walkerasarah whydohospitalprescriberscontinueantibioticswhenitissafetostopresultsofachoiceexperimentsurvey AT llewelynmartinj whydohospitalprescriberscontinueantibioticswhenitissafetostopresultsofachoiceexperimentsurvey AT wordsworthsarah whydohospitalprescriberscontinueantibioticswhenitissafetostopresultsofachoiceexperimentsurvey |